Search

Your search keyword '"Miro, Jose M."' showing total 867 results

Search Constraints

Start Over You searched for: Author "Miro, Jose M." Remove constraint Author: "Miro, Jose M."
867 results on '"Miro, Jose M."'

Search Results

1. Efficacy and safety of antistaphylococcal penicillin or cephazolin-based combinations versus monotherapy for methicillin-susceptible Staphylococcus aureus infective endocarditis: A propensity score analysis of nationwide prospective cohort

3. The hidden side of infective endocarditis: Diagnostic and management of 500 consecutive cases in noncardiac surgery centers (2009–2018)

4. Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial

5. Major cardiovascular events after COVID-19 in people with HIV

8. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

11. Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration

14. High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial

18. Immunological and virological findings in a patient with exceptional post-treatment control: a case report

19. Overview of SARS-CoV-2 infection in adults living with HIV

20. Infective Endocarditis in Patients on Chronic Hemodialysis

21. Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV‐positive individuals

22. Daptomycin Dose-Ranging Evaluation with Single-Dose versus Multidose Ceftriaxone Combinations against Streptococcus mitis/oralis in an Ex Vivo Simulated Endocarditis Vegetation Model.

23. Mutations in cdsA and pgsA Correlate with Daptomycin Resistance in Streptococcus mitis and S. oralis.

24. Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium

25. HIV replication and tuberculosis risk among people living with HIV in Europe: A multicohort analysis, 1983–2015.

26. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study

27. Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium

28. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study

29. Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study

30. Perturbations of Phosphatidate Cytidylyltransferase (CdsA) Mediate Daptomycin Resistance in Streptococcus mitis/oralis by a Novel Mechanism

33. Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis

34. No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/[micro]L

37. External Validation of the 2023 Duke–International Society for Cardiovascular Infectious Diseases Diagnostic Criteria for Infective Endocarditis

38. Reply to Villareal and El-Altrouni: Clarifications of the 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis.

40. Leishmaniasis and HIV

41. Prevalence, risk factors and the impact of tenofovir treatment in SARS-CoV-2 infection and COVID-19 disease among people living with HIV: A cross-sectional population-based study

43. Role of age and comorbidities in mortality of patients with infective endocarditis

44. Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study)

45. Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults

46. Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018)

47. Multilocus microsatellite genotyping array for investigation of genetic epidemiology of Pneumocystis jirovecii.

48. External Validation of the 2023 Duke–International Society for Cardiovascular Infectious Diseases Diagnostic Criteria for Infective Endocarditis.

Catalog

Books, media, physical & digital resources